Jeffrey P. George insider trades
Open-market stock purchases and sales by Jeffrey P. George, Director at LENZ Therapeutics, Inc, from SEC Form 4 filings since Dec 14, 2019.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +101%.